Pacific Biosc California (PACB.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov6

Daniel Brennan Maintains Buy Rating for Pacific Biosciences

12:07

Pacific Biosc California released FY2025 9 Months Earnings on November 5 After-Market (EST), actual revenue USD 115.36M, actual EPS USD -1.71

00:00

Pacific Biosc California released FY2025 Q3 earnings on November 5 After-Market (EST), actual revenue USD 38.44M (forecast USD 40.25M), actual EPS USD -0.13 (forecast USD -0.1465)

00:00

Nov4

NMPA Approves Sequel II CNDx System for Thalassemia Diagnosis

14:34

Oct29

Pacific Biosc California to Release FY2025 Q3 Earnings on November 5 After-Market EST, Forecast Revenue USD 40.25 M, EPS USD -0.152

00:38

Oct27

Mikson CFA Rates Pacific Biosciences and Other Stocks

11:37

Schedules & Filings

Schedules

Filings

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 38.44 M, Net Income -38 M, EPS -0.13

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 39.77 M, Net Income -41.93 M, EPS -0.14

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 37.15 M, Net Income -426.08 M, EPS -1.44

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change